Suppr超能文献

骨质疏松症的药物使用模式:对指南、治疗率及质量改进干预措施的评估

Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions.

作者信息

Solomon Daniel H, Morris Charles, Cheng Hailu, Cabral Danielle, Katz Jeffrey N, Finkelstein Joel S, Avorn Jerry

机构信息

Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass 02120, USA.

出版信息

Mayo Clin Proc. 2005 Feb;80(2):194-202. doi: 10.4065/80.2.194.

Abstract

OBJECTIVE

To assess current osteoporosis treatment guidelines, studies of osteoporosis treatment, and interventions to improve osteoporosis treatment.

METHODS

We searched the medical literature for articles published between January 1, 1992, and December 31, 2003, and assessed all relevant articles using a structured data abstraction process. Because of substantial heterogeneity in study design, no attempt was made to summarize the data using meta-analytic techniques.

RESULTS

Seventy-six articles met criteria for inclusion. Eighteen practice guidelines were studied. Most guidelines were consistent in key treatment recommendations. Among 18 studies of treatment rates in patients who had fractures, the weighted average varied from 22% for nonhormonal treatment to 19% for calcium. We found slightly higher treatment rates for patients taking oral glucocorticoids or for those older than 65 years. There were no consistent correlates of which patients received treatment. Six studies that examined treatment frequencies after bone densitometry all found that patients with lower bone mineral density were more likely to receive treatment. Most of the 8 interventions designed to improve osteoporosis treatment showed improvement in treatment rates; however, only 3 were randomized, and these showed the smallest effects.

CONCLUSIONS

Frequency of treatment of osteoporosis in at-risk populations is low. However, our assessment of the literature revealed no clear and consistent predictors of undertreatment. Few carefully controlled interventions have been reported.

摘要

目的

评估当前骨质疏松症治疗指南、骨质疏松症治疗研究以及改善骨质疏松症治疗的干预措施。

方法

我们检索了1992年1月1日至2003年12月31日期间发表的医学文献,并使用结构化数据提取流程评估了所有相关文章。由于研究设计存在很大异质性,未尝试使用荟萃分析技术对数据进行总结。

结果

76篇文章符合纳入标准。研究了18项实践指南。大多数指南在关键治疗建议上是一致的。在18项关于骨折患者治疗率的研究中,加权平均值从非激素治疗的22%到钙剂治疗的19%不等。我们发现服用口服糖皮质激素的患者或65岁以上患者的治疗率略高。对于哪些患者接受治疗,没有一致的关联因素。6项检查骨密度测定后治疗频率的研究均发现,骨密度较低的患者更有可能接受治疗。旨在改善骨质疏松症治疗的8项干预措施中的大多数显示治疗率有所提高;然而,只有3项是随机的,且这些显示的效果最小。

结论

高危人群中骨质疏松症的治疗频率较低。然而,我们对文献的评估显示,没有明确且一致的治疗不足预测因素。很少有经过仔细对照的干预措施被报道。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验